Braun-Bostich & Associates’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $439K | Sell |
477
-42
| -8% | -$42.6K | 0.27% | 63 |
|
|
2025
Q4 | $558K | Buy |
519
+16
| +3% | +$15.3K | 0.34% | 56 |
|
|
2025
Q3 | $384K | Sell |
503
-24
| -5% | -$17.9K | 0.24% | 74 |
|
|
2025
Q2 | $411K | Buy |
527
+13
| +3% | +$10.1K | 0.28% | 67 |
|
|
2025
Q1 | $425K | Buy |
514
+6
| +1% | +$4.99K | 0.31% | 66 |
|
|
2024
Q4 | $392K | Sell |
508
-40
| -7% | -$33.1K | 0.28% | 67 |
|
|
2024
Q3 | $485K | Sell |
548
-6
| -1% | -$5.39K | 0.34% | 55 |
|
|
2024
Q2 | $502K | Buy |
554
+71
| +15% | +$56.8K | 0.37% | 55 |
|
|
2024
Q1 | $376K | Buy |
483
+67
| +16% | +$47.7K | 0.31% | 78 |
|
|
2023
Q4 | $242K | Buy |
+416
| New | +$243K | 0.22% | 109 |
|
|
2023
Q3 | – | Sell |
-427
| Closed | -$200K | – | 80 |
|
|
2023
Q2 | $200K | Buy |
+427
| New | +$179K | 0.43% | 76 |
|
|
2020
Q4 | – | Sell |
-323
| Closed | -$48K | – | 143 |
|
|
2020
Q3 | $48K | Sell |
323
-221
| -41% | -$34.2K | 0.05% | 154 |
|
|
2020
Q2 | $89K | Hold |
544
| – | – | 0.09% | 108 |
|
|
2020
Q1 | $74K | Hold |
544
| – | – | 0.09% | 112 |
|
|
2019
Q4 | $72K | Buy |
+544
| New | +$63.1K | 0.07% | 133 |
|
|
2019
Q3 | – | Sell |
-1,656
| Closed | -$183K | – | 206 |
|
|
2019
Q2 | $183K | Sell |
1,656
-105
| -6% | -$12.4K | 0.19% | 100 |
|
|
2019
Q1 | $229K | Sell |
1,761
-378
| -18% | -$46K | 0.24% | 91 |
|
|
2018
Q4 | $248K | Sell |
2,139
-5,675
| -73% | -$634K | 0.26% | 91 |
|
|
2018
Q3 | $839K | Sell |
7,814
-244
| -3% | -$24.4K | 0.81% | 32 |
|
|
2018
Q2 | $688K | Sell |
8,058
-445
| -5% | -$36.5K | 0.69% | 43 |
|
|
2018
Q1 | $658K | Buy |
8,503
+82
| +1% | +$6.6K | 0.57% | 56 |
|
|
2017
Q4 | $711K | Buy |
+8,421
| New | +$717K | 0.6% | 44 |
|
Other funds holding LLY
VCM
VPM
